We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DY icon
976
Dycom Industries
DY
$12.2B
$25.3M 0.01%
149,723
+45,809
+44% +$7.15M
TTMI icon
977
TTM Technologies
TTMI
$14.1B
$25.2M 0.01%
1,297,714
+158,851
+14% +$2.71M
CVE icon
978
Cenovus Energy
CVE
$54.4B
$25.2M 0.01%
1,281,507
-742,752
-37% -$15M
EQC
979
DELISTED
Equity Commonwealth
EQC
$25.2M 0.01%
1,297,590
+813,696
+168% +$15.5M
B
980
Barrick Mining
B
$68.4B
$25.1M 0.01%
1,503,954
-3,979
-0.3% -$67.5K
SILK
981
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$25M 0.01%
926,327
+530,091
+134% +$11M
CUBI icon
982
Customers Bancorp
CUBI
$2.76B
$25M 0.01%
520,951
-52,741
-9% -$2.49M
DNLI icon
983
Denali Therapeutics
DNLI
$3.95B
$24.9M 0.01%
1,073,857
+565,661
+111% +$10.9M
ORI icon
984
Old Republic International
ORI
$10.3B
$24.9M 0.01%
804,715
+78,919
+11% +$2.42M
RSI icon
985
Rush Street Interactive
RSI
$2.87B
$24.8M 0.01%
2,590,441
+1,775,662
+218% +$14.2M
COHR icon
986
Coherent
COHR
$65.8B
$24.8M 0.01%
342,472
-4,143
-1% -$249K
INGR icon
987
Ingredion
INGR
$6.54B
$24.8M 0.01%
216,110
-9,327
-4% -$1.08M
KD icon
988
Kyndryl
KD
$2.99B
$24.8M 0.01%
941,640
-35,124
-4% -$842K
TMDX icon
989
Transmedics
TMDX
$3B
$24.8M 0.01%
164,327
+79,967
+95% +$9.59M
ALKS icon
990
Alkermes
ALKS
$8.23B
$24.7M 0.01%
1,026,002
-225,297
-18% -$5.53M
LAD icon
991
Lithia Motors
LAD
$8.23B
$24.7M 0.01%
97,920
-2,332
-2% -$610K
LAUR icon
992
Laureate Education
LAUR
$5.21B
$24.7M 0.01%
1,654,444
-743,036
-31% -$11.1M
KFY icon
993
Korn Ferry
KFY
$4.27B
$24.7M 0.01%
368,125
+4,579
+1% +$294K
LNW
994
DELISTED
Light & Wonder
LNW
$24.7M 0.01%
235,427
-70,101
-23% -$6.7M
SBRA icon
995
Sabra Healthcare REIT
SBRA
$5.29B
$24.6M 0.01%
1,599,660
-309,801
-16% -$4.43M
AAT
996
American Assets Trust
AAT
$1.38B
$24.6M 0.01%
1,100,228
-109,879
-9% -$2.36M
RPRX icon
997
Royalty Pharma
RPRX
$25.6B
$24.6M 0.01%
932,441
-45,265
-5% -$1.25M
BSV icon
998
Vanguard Short-Term Bond ETF
BSV
$45.6B
$24.6M 0.01%
320,431
CXT icon
999
Crane NXT
CXT
$2.95B
$24.6M 0.01%
399,971
+47,861
+14% +$2.93M
PCVX icon
1000
Vaxcyte
PCVX
$8.71B
$24.6M 0.01%
325,161
+13,809
+4% +$940K

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.